Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 10.05.2024
MPH Health Care AG
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG
(ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 62,00 auf EUR 81,00.
Zusammenfassung:
Die vorläufigen Ergebnisse entsprachen weitgehend unseren Erwartungen. Der
JE23 Nettoinventa [ … ]
Fri, 10.05.2024
Knaus Tabbert AG
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG
(ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 86,00.
Zusammenfassung:
Knaus Tabbert hat das Jahr mit einem soliden Q1-Bericht begonnen. Nach dem
Blockbuster-Wachstum von 37% im Ja [ … ]
Fri, 10.05.2024
ZEAL Network SE
Staggering Q1 kicks off new growth phase; chg est. & PT
On Wednesday, ZEAL released staggering Q1 results above expectations with
strong sales growth and better than expected profitability. Moreover, ZEAL
substantially improved marketing efficiency which drove customer growth to
record levels. In detail:
Strong Lottery business: Lottery b [ … ]
Fri, 10.05.2024
Nynomic AG
Solid start into FY24 despite challenging end markets
Topic: Nynomic published a solid start into the year with order intake
returning to growth for the first time since Q3 2022. Similar to FY23, this
year’s operational performance should again be back-end loaded.
Preliminary Q1 sales grew by 6.5% yoy to € 23m thanks to consolidati [ … ]
Fri, 10.05.2024
R. STAHL AG
Final Q1 out // Good start into 2024; chg. est.
Topic: R. Stahl reported a solid final Q1 underpinning the strong demand
for electrical explosion protection solutions, which should continue due to
favorable structural trends. Management confirmed FY24e guidance, which
looks well in reach (eNuW).
To recap, Q1 sales grew 8.5% yoy to € 84.7 [ … ]
Wed, 08.05.2024
Deutsche Rohstoff AG
First Berlin Equity Research has published a research update on Deutsche
Rohstoff AG (ISIN: DE000A0XYG76). Analyst Simon Scholes downgraded the
stock to ADD and decreased the price target from EUR 54.00 to EUR 51.00.
Abstract:
DRAG's final 2023 numbers were very close to the preliminary figures
published in February. Revenue climbed 18.9% to &e [ … ]
Wed, 08.05.2024
Warimpex Finanz- und Beteiligungs AG
While they were better than our estimates on the revenue and EBITDA level,
Warimpex’ EBIT and net income disappointed due to an unexpected
remeasurement loss of EUR 38.3m (thereof: EUR 36.7m in Russia), which
resulted from higher interest rates and lower expected rent income. Both
factors currently affect the whole real estate sector. Posit [ … ]
Wed, 08.05.2024
Media and Games Invest SE
First Berlin Equity Research hat ein Research Update zu Media and Games
Invest SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin
bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 3,80 auf EUR
4,10.
Zusammenfassung:
Der Dreimonatsbericht setzte die Reihe positiver Nachrichten im Jahr 2024,
wie die Rück [ … ]
Wed, 08.05.2024
Borussia Dortmund GmbH & Co KGaA
Third final in club history guarantees extra profit / chg.
On Tuesday, BVB visited Paris St. Germain for the second leg of the UEFA
Champions League semifinal. Thanks to a 1-0 victory, the team managed to
advance to the final for the first time since 2013. With this, the club can
now expect additional UEFA prize money payments of at least &euro [ … ]
Tue, 07.05.2024
LAIQON AG
Capital increase to secure further growth
On Saturday, LAIQON announced a cash capital increase in order to secure
further growth and expects 85% of its 20/24 convertible bond holders to
convert into equity by end of May.
The cash capital increase without subscription rights (up to 5.7% or 1.0m
shares) priced at € 6.25 per share should [ … ]